Clinical characteristics and outcomes of varicella zoster virus infection in children with hematologic malignancies in the acyclovir era

Background Although intravenous acyclovir therapy is recommended for varicella zoster virus (VZV) infection in immunocompromised children, the clinical characteristics and outcomes of VZV infection in the acyclovir era have rarely been reported.